[Xanthomatosis as a symptom of hyperlipidemic metabolic disorders. Relationship of the morphological picture to the lipid of three patients].
D000328:Adult; D001157:Arterial Occlusive Diseases / Q000209:etiology; D001797:Blood Protein Electrophoresis; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000209:etiology; D004038:Diet, Reducing; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000145:classification / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D008074:Lipoproteins / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D014973:Xanthomatosis / Q000150:complications*
D002914:Chylomicrons; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D002994:Clofibrate
Xanthomatosen als Symptom von hyperlipidämischen Stoffwehselstörungen.